These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38557779)
1. Variants in autophagy genes MTMR12 and FAM134A are putative modifiers of the hepatic phenotype in α1-antitrypsin deficiency. Tafaleng EN; Li J; Wang Y; Hidvegi T; Soto-Gutierrez A; Locke AE; Nicholas TJ; Wang YC; Pak S; Cho MH; Silverman EK; Silverman GA; Jin SC; Fox IJ; Perlmutter DH Hepatology; 2024 Oct; 80(4):859-871. PubMed ID: 38557779 [TBL] [Abstract][Full Text] [Related]
2. Multiple Genes Core to ERAD, Macroautophagy and Lysosomal Degradation Pathways Participate in the Proteostasis Response in α1-Antitrypsin Deficiency. Li J; Moretti F; Hidvegi T; Sviben S; Fitzpatrick JAJ; Sundaramoorthi H; Pak SC; Silverman GA; Knapp B; Filipuzzi I; Alford J; Reece-Hoyes J; Nigsch F; Murphy LO; Nyfeler B; Perlmutter DH Cell Mol Gastroenterol Hepatol; 2024; 17(6):1007-1024. PubMed ID: 38336172 [TBL] [Abstract][Full Text] [Related]
3. Regulation of PGC1α Downstream of the Insulin Signaling Pathway Plays a Role in the Hepatic Proteotoxicity of Mutant α1-Antitrypsin Deficiency Variant Z. Rudnick DA; Huang J; Hidvegi T; Chu AS; Hale P; Munanairi A; Dietzen DJ; Cliften PF; Tycksen E; Lutkewitte AJ; Finck BN; Pak SC; Silverman GA; Perlmutter DH Gastroenterology; 2022 Jul; 163(1):270-284. PubMed ID: 35301011 [TBL] [Abstract][Full Text] [Related]
4. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Hidvegi T; Ewing M; Hale P; Dippold C; Beckett C; Kemp C; Maurice N; Mukherjee A; Goldbach C; Watkins S; Michalopoulos G; Perlmutter DH Science; 2010 Jul; 329(5988):229-32. PubMed ID: 20522742 [TBL] [Abstract][Full Text] [Related]
5. Targeting intracellular degradation pathways for treatment of liver disease caused by α1-antitrypsin deficiency. Wang Y; Perlmutter DH Pediatr Res; 2014 Jan; 75(1-2):133-9. PubMed ID: 24226634 [TBL] [Abstract][Full Text] [Related]
6. α1-antitrypsin Deficiency: A Misfolded Secretory Protein Variant with Unique Effects on the Endoplasmic Reticulum. Perlmutter DH Endoplasmic Reticulum Stress Dis; 2016 Sep; 3(1):63-72. PubMed ID: 28217691 [TBL] [Abstract][Full Text] [Related]
7. Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiency. Li J; Pak SC; O'Reilly LP; Benson JA; Wang Y; Hidvegi T; Hale P; Dippold C; Ewing M; Silverman GA; Perlmutter DH PLoS One; 2014; 9(1):e87260. PubMed ID: 24498058 [TBL] [Abstract][Full Text] [Related]
8. The role of autophagy in alpha-1-antitrypsin deficiency. Hidvegi T; Mukherjee A; Ewing M; Kemp C; Perlmutter DH Methods Enzymol; 2011; 499():33-54. PubMed ID: 21683248 [TBL] [Abstract][Full Text] [Related]
9. The endoplasmic reticulum degradation pathway for mutant secretory proteins alpha1-antitrypsin Z and S is distinct from that for an unassembled membrane protein. Teckman JH; Perlmutter DH J Biol Chem; 1996 May; 271(22):13215-20. PubMed ID: 8662752 [TBL] [Abstract][Full Text] [Related]
10. Genetic variants of alpha1-antitrypsin. Salahuddin P Curr Protein Pept Sci; 2010 Mar; 11(2):101-17. PubMed ID: 19751191 [TBL] [Abstract][Full Text] [Related]
11. The Autophagy Pathway: A Critical Route in the Disposal of Alpha 1-Antitrypsin Aggregates That Holds Many Mysteries. Leon C; Bouchecareilh M Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668611 [TBL] [Abstract][Full Text] [Related]
13. A transgenic zebrafish model of hepatocyte function in human Z α1-antitrypsin deficiency. Yip E; Giousoh A; Fung C; Wilding B; Prakash MD; Williams C; Verkade H; Bryson-Richardson RJ; Bird PI Biol Chem; 2019 Nov; 400(12):1603-1616. PubMed ID: 31091192 [TBL] [Abstract][Full Text] [Related]
14. Alpha-1 antitrypsin and liver disease: mechanisms of injury and novel interventions. Teckman JH; Mangalat N Expert Rev Gastroenterol Hepatol; 2015 Feb; 9(2):261-8. PubMed ID: 25066184 [TBL] [Abstract][Full Text] [Related]
15. Induced pluripotent stem cells model personalized variations in liver disease resulting from α1-antitrypsin deficiency. Tafaleng EN; Chakraborty S; Han B; Hale P; Wu W; Soto-Gutierrez A; Feghali-Bostwick CA; Wilson AA; Kotton DN; Nagaya M; Strom SC; Roy-Chowdhury J; Stolz DB; Perlmutter DH; Fox IJ Hepatology; 2015 Jul; 62(1):147-57. PubMed ID: 25690322 [TBL] [Abstract][Full Text] [Related]
16. Capitalizing on the autophagic response for treatment of liver disease caused by alpha-1-antitrypsin deficiency and other genetic diseases. Chu AS; Perlmutter DH; Wang Y Biomed Res Int; 2014; 2014():459823. PubMed ID: 25025052 [TBL] [Abstract][Full Text] [Related]
17. Liver in alpha1-antitrypsin deficiency: morphologic observations and in vitro synthesis of alpha1-antitrypsin. Bhan AK; Grand RJ; Colten HR; Alper CA Pediatr Res; 1976 Jan; 10(1):35-40. PubMed ID: 1082120 [TBL] [Abstract][Full Text] [Related]
18. NFκB mitigates the pathological effects of misfolded α1-antitrypsin by activating autophagy and an integrated program of proteostasis mechanisms. Mukherjee A; Hidvegi T; Araya P; Ewing M; Stolz DB; Perlmutter DH Cell Death Differ; 2019 Mar; 26(3):455-469. PubMed ID: 29795336 [TBL] [Abstract][Full Text] [Related]
19. Mysteries of α1-antitrypsin deficiency: emerging therapeutic strategies for a challenging disease. Ghouse R; Chu A; Wang Y; Perlmutter DH Dis Model Mech; 2014 Apr; 7(4):411-9. PubMed ID: 24719116 [TBL] [Abstract][Full Text] [Related]
20. Fasting in alpha1-antitrypsin deficient liver: constitutive [correction of consultative] activation of autophagy. Teckman JH; An JK; Loethen S; Perlmutter DH Am J Physiol Gastrointest Liver Physiol; 2002 Nov; 283(5):G1156-65. PubMed ID: 12381530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]